Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 1/2025

Content (10 Articles)

Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes

  • Mpox
  • Leading Article

Youssef Rizk, Giuseppe Lippi, Brandon M. Henry, Kin Israel Notarte, John G. Rizk

Drugs in Development to Manage Acute Pain

Brian Oliver, Catherine Devitt, Grace Park, Alina Razak, Sun Mei Liu, Sergio D. Bergese

Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections

Alina Iovleva, Vance G. Fowler Jr., Yohei Doi

Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations

Ehab Atallah, Michael Deininger

Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy

Sha Li, Hui-Hui Liu, Jian-Jun Li

Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations

Ole Haagen Nielsen, Alexander Hammerhøj, Mark Andrew Ainsworth, John Gubatan, Geert D’Haens

Long-Term Self-Administered Outpatient Parenteral Antimicrobial Therapy in the Treatment of Tuberculosis

A. Rauch, N. Köhler, T. T. Brehm, N. Zielinski, K. Stoycheva, C. Maier, L. Böttcher, I. Friesen, D. Schaub, M. Reimann, S. Schmiedel, C. Lange, B. Kalsdorf

Xeligekimab: First Approval

Hannah A. Blair

Xanomeline/Trospium Chloride: First Approval

Yahiya Y. Syed

Arimoclomol: First Approval

Susan J. Keam

Dec 24
Issue: 12/2024
Feb 25
Issue: 2/2025

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images